Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/99494
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pérez Bosch, Maria | - |
dc.contributor.author | Espadinha, Margarida | - |
dc.contributor.author | Santos, Maria M. M. | - |
dc.date.accessioned | 2016-06-13T15:27:47Z | - |
dc.date.available | 2016-07-25T22:01:21Z | - |
dc.date.issued | 2015-07-25 | - |
dc.identifier.issn | 1381-6128 | - |
dc.identifier.uri | http://hdl.handle.net/2445/99494 | - |
dc.description.abstract | Corynantheine alkaloids with a tetracyclic indole[2,3-a]-quinolizidine motif are an important issue in academia and in the life science industries due to their broad bioactivity profile. In particular, the main biological effects described for indoloquinolizidines include analgesic, anti-inflammatory, antihypertensive, and antiarrhythmic activities, as well as inhibition of multiple ion channels, affinity for opioid receptors, and activity against Leishmania. For that reason, in the last decades, numerous efforts have been invested in the development of novel synthetic strategies to obtain the indole[2,3-a]-quinolizidine system. This review focuses on the synthetic methodologies developed to target the most important alkaloids of this family, and highlights the potential use of these alkaloids or analogs to treat several diseases, ranging from cancer to neurodegenerative disorders. | - |
dc.format.extent | 29 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Bentham Science Publishers | - |
dc.relation.isformatof | Versió postprint del document publicat a: http://dx.doi.org/10.2174/1381612821666151002112934 | - |
dc.relation.ispartof | Current Pharmaceutical Design, 2015, vol. 21, num. 38, p. 5518-5546 | - |
dc.relation.uri | http://dx.doi.org/10.2174/1381612821666151002112934 | - |
dc.rights | (c) Bentham Science Publishers, 2015 | - |
dc.source | Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) | - |
dc.subject.classification | Síntesi asimètrica | - |
dc.subject.classification | Alcaloides | - |
dc.subject.classification | Productes naturals | - |
dc.subject.other | Asymmetric synthesis | - |
dc.subject.other | Alkaloids | - |
dc.subject.other | Natural products | - |
dc.title | Indolo[2,3-a]quinolizidines and derivatives: Bioactivity and asymmetric Synthesis | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 653895 | - |
dc.date.updated | 2016-06-13T15:27:52Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 26429714 | - |
Appears in Collections: | Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) Articles publicats en revistes (Institut de Biomedicina (IBUB)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
653895.pdf | 4.29 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.